On this page
RS1
retinoschisin 1
RS1 is located on the short (p) arm of chromosome X, at band Xp22.13. Arm ratio per GRCh38 - banding schematic.
Explore chromosome X in the library →Available at Jeen Health
Clinical tests that include this
Overview
The RS1 gene, located on the X chromosome, encodes retinoschisin, a protein essential for the structural organisation of the retina. The retina is the specialised light-sensitive tissue lining the back of the eye, responsible for converting light into neural signals. Retinoschisin functions primarily as a cell-adhesion molecule, binding to photoreceptor cells and bipolar cells to maintain the layered architecture of retinal tissue.
Pathogenic variants in RS1 disrupt normal retinal organisation, leading to X-linked juvenile retinoschisis, an inherited eye disorder that primarily affects males. This condition causes splitting or tearing within retinal layers, resulting in progressive vision deterioration. Because RS1 follows X-linked inheritance, females who carry one altered copy typically do not develop symptoms but can pass the variant to their children.
What the gene does
Retinoschisin serves as a critical organising protein within the retina, facilitating the proper arrangement and adhesion of specialised retinal cells. The protein binds to the surface of photoreceptor cells, which detect light and colour, as well as to bipolar cells that relay visual signals to other retinal neurons. Research suggests that retinoschisin maintains the structural integrity of these cellular layers by promoting cell-to-cell adhesion, preventing the formation of splits or gaps.
During retinal development and throughout life, retinoschisin appears to coordinate the spatial organisation of retinal cells, ensuring they remain properly aligned within distinct layers. This adhesive function is particularly important for maintaining the connection between photoreceptors and supporting cells. When retinoschisin function is compromised, the retina's layered architecture becomes unstable, leading to the characteristic splitting seen in retinoschisis. The protein's role extends beyond simple structural support, potentially influencing cellular signalling pathways that regulate retinal health and visual processing.
Video: Genetics 101
Chromosome location
RS1 is located on the short arm of the X chromosome at position Xp22.13. This chromosomal band lies near the telomeric end of the X chromosome's short arm. The gene's location on the X chromosome determines its inheritance pattern: males, who have only one X chromosome, develop the condition if they inherit an altered copy, whilst females with two X chromosomes are typically unaffected carriers. The specific chromosomal position has been well characterised in clinical genetic testing and diagnostic panels for X-linked retinal disorders.
Protein structure
The retinoschisin protein comprises 224 amino acids and contains a conserved F5/8 type C domain spanning amino acids 63 to 219. This domain, also known as a discoidin domain, is characteristic of proteins involved in cell adhesion and membrane interactions. The F5/8 type C domain is structurally similar to regions found in blood coagulation factors V and VIII, suggesting an evolutionary relationship between these adhesion-related proteins. This domain structure enables retinoschisin to recognise and bind to specific molecules on retinal cell surfaces, facilitating the cell-adhesion function critical for maintaining retinal architecture. The domain's compact structure and conserved residues are essential for protein stability and proper folding.
Key variants
More than 220 pathogenic variants in RS1 have been identified in individuals with X-linked juvenile retinoschisis. The majority of these variants are missense changes, where a single amino acid substitution alters the protein's structure or function. Other types of pathogenic changes include small deletions, insertions, and variants affecting RNA splicing. Many of the missense variants cluster within the F5/8 type C domain, disrupting the protein's ability to fold correctly or bind to retinal cell surfaces. The diversity of variant types reflects the multiple ways in which retinoschisin function can be compromised, all leading to similar clinical features of retinal splitting and vision impairment.
No pathogenic or likely-pathogenic ClinVar variants recorded yet for this gene.
Associated conditions
Pathogenic variants in RS1 cause X-linked juvenile retinoschisis, also referred to as X-linked retinoschisis. This condition is characterised by the formation of tiny splits or tears within the retinal layers, particularly affecting the macula, the central region responsible for detailed vision. Males with X-linked juvenile retinoschisis typically experience progressive vision loss beginning in childhood or adolescence, though severity can vary considerably. The splitting of retinal tissue disrupts normal visual signal processing, leading to reduced visual acuity, difficulty with central vision, and in some cases, complications such as retinal detachment. Female carriers generally do not develop symptoms but may show subtle retinal changes on detailed examination.
- X-linked juvenile retinoschisis
- X-linked retinoschisis Dedicated page coming soon
Inheritance pattern
Conditions caused by pathogenic RS1 variants typically follow x-linked inheritance.
X-linked recessive: sons of a carrier mother have a 50% chance of being affected. Daughters have a 50% chance of being carriers.
UK clinical status
RS1 is included on the NHS Genomic Medicine Service Retinal disorders panel with a green rating (R32), indicating strong evidence supporting its clinical validity for inherited retinal conditions. This classification reflects the gene's well-established role in X-linked retinoschisis and supports its use in diagnostic testing for individuals presenting with characteristic retinal splitting patterns. The panel designation facilitates access to genetic testing through NHS pathways for patients with suspected inherited retinal disease.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
Why does X-linked retinoschisis primarily affect males?
X-linked retinoschisis follows an X-linked recessive inheritance pattern. Males have only one X chromosome, so a single pathogenic RS1 variant causes the condition. Females have two X chromosomes, and typically the normal copy on the second X chromosome compensates for the altered copy, preventing symptoms in most carriers.
At what age do symptoms of X-linked retinoschisis typically appear?
Vision problems associated with X-linked retinoschisis most commonly become noticeable during childhood or adolescence, though the age of onset and severity can vary between individuals. Some affected males may be diagnosed in early childhood, whilst others may not experience significant symptoms until later.
Can females who carry an RS1 variant have any symptoms?
Female carriers of pathogenic RS1 variants generally do not develop the vision loss seen in affected males. However, detailed retinal examination may occasionally reveal subtle structural changes. Carriers can pass the variant to their children, with a 50% chance for each pregnancy.
References
- Kim DY, Mukai S. X-linked juvenile retinoschisis (XLRS): a review of genotype-phenotype relationships. Seminars in ophthalmology. 2013. PMID: 24138048
- Molday RS, Kellner U, Weber BH. X-linked juvenile retinoschisis: clinical diagnosis, genetic analysis, and molecular mechanisms. Progress in retinal and eye research. 2012. PMID: 22245536
- Yi J, Li S, Jia X. Novel RS1 mutations associated with X-linked juvenile retinoschisis. International journal of molecular medicine. 2012. PMID: 22245991
- Molday RS. Focus on molecules: retinoschisin (RS1). Experimental eye research. 2007. PMID: 16600216
- Wu WW, Wong JP, Kast J. RS1, a discoidin domain-containing retinal cell adhesion protein associated with X-linked retinoschisis, exists as a novel disulfide-linked octamer. The Journal of biological chemistry. 2005. PMID: 15644328
- Pimenides D, George ND, Yates JR. X-linked retinoschisis: clinical phenotype and RS1 genotype in 86 UK patients. Journal of medical genetics. 2005. PMID: 15937075